Forge Biologics’ $120 Million Series B Financing

Wilson Sonsini Goodrich & Rosati advised RA Capital Management on the deal.Forge Biologics, a gene therapy-focused contract development and manufacturing organization, announced the closing of a…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now